PRCSG News
Abstracts / Posters / Presentations
21 PANLAR 2019, April 27 - 30
- Efficacy and safety of intravenous golimumab in patients with juvenile idiopathic arthritis: Results from a Phase 3 open-label study (#323)
*******************************************************************************************
April 2019 - FDA approves Benlysta (belimumab) for children with lupus who are five years old or above
September 2018 - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA
Revised Common Rule: educational videos created by OHRP
May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis